PLAINSBORO, N.J., May 1, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NasdaqGS:IART - News) will feature the OSVII Low Pro(TM) Valve, a low profile version of the OSVII(R) Flow-Controlled Hydrocephalus Valve, at the American Association of Neurological Surgeons Annual Meeting in San Diego, California, May 2-6, 2009. The Integra OSVII Low Pro(TM) Valve is Integra’s newest implantable shunt used in the treatment of hydrocephalus, and was designed with a lower profile to accommodate various patient populations, particularly pediatric patients.
